US and Europe biosimilars, clinical trials in EU & US

Patient recruitment challenges for clinical trials

Effective recruitment of patients is one of the most important ingredients for a successful clinical trial. Yet, today, 11% of clinical research sites fail to enroll even a single participant, and nearly 90% of clinical trials experience significant delays due to issues with patient recruitment. 

Over 40 years after Dr Louis Lasagna came up with his law of progressively diminishing returns in patient recruitment, the problem still looms large for drug developers. This article by Cromos Pharma’s CEO, Vlad Bogin, explores the continuing relevance of “Lasagna’s Law” and looks at ways to address patient recruitment challenges.

Read the article here 




To arrange an introductory meeting and find out how our experience can benefit your next clinical project.